559 related articles for article (PubMed ID: 34526087)
81. Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices.
Gaffney S; Kelly DM; Rameli PM; Kelleher E; Martin-Loeches I
APMIS; 2023 Nov; 131(11):654-667. PubMed ID: 37022291
[TBL] [Abstract][Full Text] [Related]
82. COVID-19-Associated Pulmonary Aspergillosis in a Tertiary Hospital.
Marta GC; Lorena FE; Laura MV; Angela LM; Blanca LG; Rodrigo AA; Marta SG; Santiago MG; Liliana PM; Maria Luisa SN; de la Rasilla Teresa PG
J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205852
[TBL] [Abstract][Full Text] [Related]
83. "CAPA in Progress": A New Real-Life Approach for the Management of Critically Ill COVID-19 Patients.
Carbonell N; Alcaráz MJ; Serrano-Lázaro A; Rodríguez-Gimillo M; Sánchez Ramos D; Ros F; Ferrer J; Blasco ML; Navarro D; Clari MÁ
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884988
[TBL] [Abstract][Full Text] [Related]
84. COVID-19-associated aspergillosis in a Brazilian referral centre: Diagnosis, risk factors and outcomes.
de Almeida JN; Doi AM; Watanabe MJL; Maluf MM; Calderon CL; Silva M; Pasternak J; Koga PCM; Santiago KAS; Aranha LFC; Szarf G; da Silva Teles GB; Filippi RZ; Paes VR; Baeta M; Hamerschlak N; Mangueira CLP; Martino MDV
Mycoses; 2022 Apr; 65(4):449-457. PubMed ID: 35174567
[TBL] [Abstract][Full Text] [Related]
85. Practice Guidelines for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis in an Intensive Care Setting.
Hashim Z; Neyaz Z; Marak RSK; Nath A; Nityanand S; Tripathy NK
J Intensive Care Med; 2022 Aug; 37(8):985-997. PubMed ID: 34678103
[TBL] [Abstract][Full Text] [Related]
86. Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
Cho SY; Lee DG; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH; Kim YJ; Kim HJ; Min WS; Back H; Kang S; Lee EK
Clin Ther; 2015 Sep; 37(9):2019-27. PubMed ID: 26188835
[TBL] [Abstract][Full Text] [Related]
87. COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment.
Arastehfar A; Carvalho A; van de Veerdonk FL; Jenks JD; Koehler P; Krause R; Cornely OA; S Perlin D; Lass-Flörl C; Hoenigl M
J Fungi (Basel); 2020 Jun; 6(2):. PubMed ID: 32599813
[TBL] [Abstract][Full Text] [Related]
88. Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics.
van Grootveld R; van Paassen J; Claas ECJ; Heerdink L; Kuijper EJ; de Boer MGJ; van der Beek MT;
Med Mycol; 2024 May; 62(5):. PubMed ID: 38544330
[TBL] [Abstract][Full Text] [Related]
89. Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort.
Vehreschild JJ; Rüping MJ; Wisplinghoff H; Farowski F; Steinbach A; Sims R; Stollorz A; Kreuzer KA; Hallek M; Bangard C; Cornely OA
J Antimicrob Chemother; 2010 Jul; 65(7):1466-71. PubMed ID: 20410061
[TBL] [Abstract][Full Text] [Related]
90. Prevention of acquired invasive fungal infection with decontamination regimen in mechanically ventilated ICU patients: a pre/post observational study.
Massart N; Reizine F; Dupin C; Legay F; Legris E; Cady A; Rieul G; Barbarot N; Magahlaes E; Fillatre P
Infect Dis (Lond); 2023 Apr; 55(4):263-271. PubMed ID: 36694427
[TBL] [Abstract][Full Text] [Related]
91. Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis.
Jenks JD; Hoenigl M; Thompson GR
Contemp Clin Trials Commun; 2024 Jun; 39():101310. PubMed ID: 38832095
[TBL] [Abstract][Full Text] [Related]
92. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.
Flikweert AW; Grootenboers MJJH; Yick DCY; du Mée AWF; van der Meer NJM; Rettig TCD; Kant MKM
J Crit Care; 2020 Oct; 59():149-155. PubMed ID: 32674001
[TBL] [Abstract][Full Text] [Related]
93. New insights into development and mortality of COVID-19-associated pulmonary aspergillosis in a homogenous cohort of 1161 intensive care patients.
Hashim Z; Nath A; Khan A; Neyaz Z; Marak RSK; Areekkara P; Tiwari A; Srivastava S; Agarwal V; Saxena S; Tripathy N; Azim A; Gupta M; Mishra DP; Mishra P; Singh RK; Gupta D; Gupta A; Sanjeev OP; Ghatak T; Ghoshal U; Dhiman RK; Tripathy NK
Mycoses; 2022 Nov; 65(11):1010-1023. PubMed ID: 35716344
[TBL] [Abstract][Full Text] [Related]
94. The Clinical Significance of Aspergillus Detected in Lower-Respiratory-Tract Samples of Critically Ill COVID-19-Positive Patients.
Osman H; Shaik AN; Nguyen PL; Cantor Z; Kaafarani M; Soubani AO
Adv Respir Med; 2023 Sep; 91(5):337-349. PubMed ID: 37736973
[No Abstract] [Full Text] [Related]
95. Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.
Lamoth F; Lewis RE; Walsh TJ; Kontoyiannis DP
J Infect Dis; 2021 Nov; 224(10):1631-1640. PubMed ID: 33770176
[TBL] [Abstract][Full Text] [Related]
96. Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant.
Wang Y; Yao Y; Zhang Q; Chen H; He Y; Hu K
BMC Infect Dis; 2024 Jan; 24(1):117. PubMed ID: 38263011
[TBL] [Abstract][Full Text] [Related]
97. Cumulative steroid dose in hospitalized patients and COVID-19-associated pulmonary aspergillosis.
Ramonfaur D; Salto-Quintana JN; Aguirre-García GM; Hernández-Mata NM; Villanueva-Lozano H; Torre-Amione G; Martínez-Reséndez MF
J Hosp Infect; 2023 Dec; 142():26-31. PubMed ID: 37499762
[TBL] [Abstract][Full Text] [Related]
98. The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients.
Zhang P; He Z; Yu G; Peng D; Feng Y; Ling J; Wang Y; Li S; Bian Y
Clin Nutr; 2021 Feb; 40(2):534-541. PubMed ID: 32527576
[TBL] [Abstract][Full Text] [Related]
99. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
[TBL] [Abstract][Full Text] [Related]
100. COVID-Associated Pulmonary Aspergillosis and Its Related Outcomes: A Single-Center Prospective Observational Study.
Iqbal A; Ramzan M; Akhtar A; Ahtesham A; Aslam S; Khalid J
Cureus; 2021 Aug; 13(8):e16982. PubMed ID: 34527462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
